| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/05/2003 | CN1394601A Joint chemical therapy method |
| 02/05/2003 | CN1394600A Peroral and pernasal administration compound and dry powder inhalant and its preparation method |
| 02/05/2003 | CN1394599A Preparation method of medicinal antimony sulfide nano colloidal particles |
| 02/05/2003 | CN1394598A Dosage form with crispness coating and soft kernel |
| 02/05/2003 | CN1394597A Process for preparing powder preparation |
| 02/05/2003 | CN1394596A Peroral and pernasal administration compound, spray and auxiliary preparation and its preparation method |
| 02/05/2003 | CN1394595A Dicaine foaming compound anesthetic |
| 02/05/2003 | CN1394591A Menthanol and menthanol lactic acid ester composite and its preparation method and application |
| 02/05/2003 | CN1100770C Hydrolysis-promoitng taxane hydrophobic derivatives |
| 02/05/2003 | CN1100711C Package of sheet-type patches |
| 02/05/2003 | CN1100570C Veterinary coposition containing proton pump inhibitor |
| 02/05/2003 | CN1100565C Interferon ointment and its preparation method |
| 02/05/2003 | CN1100555C Medicine for treating cancer |
| 02/05/2003 | CN1100554C Chinese patent drug for curing gastroptosis |
| 02/05/2003 | CN1100546C Micro-encapsulated lactobacilli for medical applications |
| 02/05/2003 | CN1100544C Mercury chloride injection |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/05/2003 | CN1100538C Lotion |
| 02/05/2003 | CN1100536C Composition for rectal administration |
| 02/04/2003 | WO2002011734A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | US6515022 Use of inhaled retinoids in the treatment of lung diseases |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6515010 Carvedilol methanesulfonate |
| 02/04/2003 | US6515009 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/04/2003 | US6515008 Formulation of H2- receptor antagonist cimetidine in liquid formulations |
| 02/04/2003 | US6514983 Inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose)polymerase |
| 02/04/2003 | US6514965 Substituted 1-benzazepines and derivatives thereof |
| 02/04/2003 | US6514958 Dosage unit comprising tibolone and a water insoluble starch product is contained in a humid atmosphere of 50 to 70% relative humidity until administration |
| 02/04/2003 | US6514951 LL-F28249 alpha-lambda or a 23-oxo or 23-imino derivative of |
| 02/04/2003 | US6514947 Formulated nucleic acid compositions and methods of administering the same for gene therapy |
| 02/04/2003 | US6514945 Azalide antibiotic compositions |
| 02/04/2003 | US6514762 Controlled release from electrodes using voltage potential difference for delivery of nucleotide into an organism; electroporation; gene therapy |
| 02/04/2003 | US6514689 Apparatus for the measurement of preferential particle in bodily fluid |
| 02/04/2003 | US6514688 Separating, detecting or quantifying biological materials using magnetic cross-linked polyvinyl alcohol particles |
| 02/04/2003 | US6514536 Drug preparations for treating sexual dysfunction |
| 02/04/2003 | US6514535 For drug delivery |
| 02/04/2003 | US6514534 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 02/04/2003 | US6514533 Device for the sustained release of aggregation-stabilized, biologically active agent |
| 02/04/2003 | US6514532 For oral administration |
| 02/04/2003 | US6514531 Controlled-release dosage forms comprising zolpidem or a salt thereof |
| 02/04/2003 | US6514530 For oral administration, comprising a semipermeable membrane surrounding a therapeutic composition comprising a dose of drug; dosage form imbibes fluid through the membrane in response to concentration gradient; sustained release |
| 02/04/2003 | US6514529 A compressed tablet of antibacterial oxazolidinone selected from the group consisting of linezolid, eperezolid and (S)-N-((3-(3-fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl-2-o xo-5-oxazolidinylmethyl)acetamide S,S-dioxide |
| 02/04/2003 | US6514526 Coated starch capsules and a process for producing them |
| 02/04/2003 | US6514525 Sustained release; mixture of non-steroid antiinflammatory drug, prostaglandin and excipient |
| 02/04/2003 | US6514524 Improved absorption of hydrophilic ingredients because of particular excipients; calcium 3-acetylamino-1-propane sulfonate (calcium acamprosate); polysorbates, fatty ethers or esters of PEG, polyglycolysed glycerides |
| 02/04/2003 | US6514523 Carrier particles for drug delivery and process for preparation |
| 02/04/2003 | US6514522 Polymer constructs |
| 02/04/2003 | US6514520 Containing about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, including salts such as disodium EDTA; especially the antihistamines loratadine, descarboethoxyloratadine, and azatadine |
| 02/04/2003 | US6514518 Multilayer solid; sustained release |
| 02/04/2003 | US6514516 Local anesthetic and a biocompatible controlled release material consisting of polyanhydrides, copolymers of lactic acid and glycolic acid, poly(lactic) acid, poly(glycolic) acid, polyesters, polyorthoesters, proteins, polysaccharides |
| 02/04/2003 | US6514514 Induces both cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; mixture of proteins, sheet |
| 02/04/2003 | US6514508 Itch reducing device and method |
| 02/04/2003 | US6514503 Mucosal administration; glyceride, antigen and vehicle |
| 02/04/2003 | US6514496 Dispersible antibody compositions and methods for their preparation and use |
| 02/04/2003 | US6514494 Bacterial strain, processed plant extracts, compostions containing same, processes for their preparation and their therapeutic and industrial applications |
| 02/04/2003 | US6514492 Methacrylic acid polymer crosslinked with divinylbenzene as the carrier; orbifloxacin; |
| 02/04/2003 | US6514491 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/04/2003 | US6514489 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 02/04/2003 | US6514484 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 02/04/2003 | US6514482 Pulmonary delivery in treating disorders of the central nervous system |
| 02/04/2003 | CA2421787A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | CA2362539C Fluorocarbon aerosol medicaments |
| 02/04/2003 | CA2268967C Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 02/04/2003 | CA2266483C Chewing gum with sweetening agent |
| 02/04/2003 | CA2122612C Pharmaceutical products for curing tumourous diseases and process for preparing same |
| 01/30/2003 | WO2003008082A1 Method and apparatus for preparing particles |
| 01/30/2003 | WO2003008026A2 Apparatus for self-induced cough-cardiopulmonary resuscitation |
| 01/30/2003 | WO2003007995A2 Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone |
| 01/30/2003 | WO2003007994A2 Thyroid therapeutic agents containing partial glycerides and dextrin |
| 01/30/2003 | WO2003007988A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 01/30/2003 | WO2003007982A1 Sustained release hgf hydrogel preparations |
| 01/30/2003 | WO2003007969A1 Bio-compatible molecules for improving vision |
| 01/30/2003 | WO2003007968A1 A cardiotonic composition |
| 01/30/2003 | WO2003007967A1 Medical preparation for parenteral injection |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | WO2003007957A1 Method and composition for treatment of cancer |
| 01/30/2003 | WO2003007928A1 Ascites preventives for poultry |
| 01/30/2003 | WO2003007922A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 01/30/2003 | WO2003007920A1 Antihistamine formulations for soft capsule dosage forms |
| 01/30/2003 | WO2003007919A1 Controlled drug delivery systems providing variable release rates |
| 01/30/2003 | WO2003007918A1 Zero order controlled drug delivery system |
| 01/30/2003 | WO2003007917A1 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 01/30/2003 | WO2003007916A1 Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate |
| 01/30/2003 | WO2003007915A2 Compositions for treatment of head and neck cancers, and methods of making and using the same |
| 01/30/2003 | WO2003007914A2 Biocompatible polymer containing composition for treatment of prostate cancers |
| 01/30/2003 | WO2003007913A2 Method for oral drug delivery |
| 01/30/2003 | WO2003007912A2 Lyophilized formulation comprising olanzapine |
| 01/30/2003 | WO2003007911A1 Method for producing articles consisting of polymer materials having a medicamentous depot effect |
| 01/30/2003 | WO2003007907A1 Water-free ubichinon concentrate |
| 01/30/2003 | WO2003007869A2 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 01/30/2003 | WO2003007867A2 A salt/ion pair medicinal aerosol formulation |
| 01/30/2003 | WO2003007846A1 Sublingual use of inhibitors in the biosynthesis of cholesterol |
| 01/30/2003 | WO2003007802A2 Pharmaceutical combinations of oxycodone and naloxone |
| 01/30/2003 | WO2003007798A2 Ophthalmic use of 5 fluorourcil |
| 01/30/2003 | WO2003007782A2 Biodegradable injectable implants and related methods of manufacture and use |
| 01/30/2003 | WO2003007733A1 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid |
| 01/30/2003 | WO2003007689A2 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/30/2003 | WO2002080885A8 Detoxification and decontamination using nanotechnology therapy |
| 01/30/2003 | WO2002069945A3 Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors |
| 01/30/2003 | WO2002066002A3 Pharmaceutical formulation |